| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |